These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 17301271
1. Toll-like receptor 4 genetic variation and advanced prostate cancer risk. Cheng I, Plummer SJ, Casey G, Witte JS. Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):352-5. PubMed ID: 17301271 [Abstract] [Full Text] [Related]
2. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ. Cancer Res; 2005 Dec 15; 65(24):11771-8. PubMed ID: 16357190 [Abstract] [Full Text] [Related]
3. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. Sun J, Wiklund F, Zheng SL, Chang B, Bälter K, Li L, Johansson JE, Li G, Adami HO, Liu W, Tolin A, Turner AR, Meyers DA, Isaacs WB, Xu J, Grönberg H. J Natl Cancer Inst; 2005 Apr 06; 97(7):525-32. PubMed ID: 15812078 [Abstract] [Full Text] [Related]
4. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk. Sun J, Wiklund F, Hsu FC, Bälter K, Zheng SL, Johansson JE, Chang B, Liu W, Li T, Turner AR, Li L, Li G, Adami HO, Isaacs WB, Xu J, Grönberg H. Cancer Epidemiol Biomarkers Prev; 2006 Mar 06; 15(3):480-5. PubMed ID: 16537705 [Abstract] [Full Text] [Related]
5. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer. Chen YC, Giovannucci E, Kraft P, Lazarus R, Hunter DJ. Cancer Epidemiol Biomarkers Prev; 2007 Oct 06; 16(10):1982-9. PubMed ID: 17932345 [Abstract] [Full Text] [Related]
6. Significant association between toll-like receptor gene polymorphisms and gallbladder cancer. Srivastava K, Srivastava A, Kumar A, Mittal B. Liver Int; 2010 Aug 06; 30(7):1067-72. PubMed ID: 20492496 [Abstract] [Full Text] [Related]
7. Polymorphisms in Toll-like receptor genes and risk of cancer. El-Omar EM, Ng MT, Hold GL. Oncogene; 2008 Jan 07; 27(2):244-52. PubMed ID: 18176606 [Abstract] [Full Text] [Related]
8. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development. Lindström S, Wiklund F, Adami HO, Bälter KA, Adolfsson J, Grönberg H. Cancer Res; 2006 Nov 15; 66(22):11077-83. PubMed ID: 17108148 [Abstract] [Full Text] [Related]
18. Evidence for association between a Toll-like receptor 4 gene polymorphism and moderate/severe periodontitis in the Japanese population. Fukusaki T, Ohara N, Hara Y, Yoshimura A, Yoshiura K. J Periodontal Res; 2007 Dec 15; 42(6):541-5. PubMed ID: 17956467 [Abstract] [Full Text] [Related]
19. Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer. Levin AM, Zuhlke KA, Ray AM, Cooney KA, Douglas JA. Prostate; 2007 Oct 01; 67(14):1507-13. PubMed ID: 17683075 [Abstract] [Full Text] [Related]